Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for Parkinson's Disease-Associated Apathy and Motor Symptoms
NCT01782222Phase 4Completed
- Sponsor
- UCB
- Start
- Feb 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of rotigotine in Parkinson's disease (PD), sponsored by UCB. Started Feb 2013; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01782222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782222.